Author:
Gu Ming,Yin Weixiang,Zhang Jiaming,Yin Junfeng,Tang Xiaofei,Ling Jie,Tang Zhijie,Yin Weijuan,Wang Xiangjun,Ni Qing,Zhu Yunxiang,Chen Tuo
Abstract
Colorectal cancer (CRC) is a major health burden, accounting for approximately 10% of all new cancer cases worldwide. Accumulating evidence suggests that the crosstalk between the host mucins and gut microbiota is associated with the occurrence and development of CRC. Mucins secreted by goblet cells not only protect the intestinal epithelium from microorganisms and invading pathogens but also provide a habitat for commensal bacteria. Conversely, gut dysbiosis results in the dysfunction of mucins, allowing other commensals and their metabolites to pass through the intestinal epithelium, potentially triggering host responses and the subsequent progression of CRC. In this review, we summarize how gut microbiota and bacterial metabolites regulate the function and expression of mucin in CRC and novel treatment strategies for CRC.
Subject
Infectious Diseases,Microbiology (medical),Immunology,Microbiology
Reference141 articles.
1. Molecular detection, quantification, and isolation of streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8;Abdulamir;Mol. Cancer,2010
2. Differential expression of mucins in middle Eastern patients with colorectal cancer;Al-Khayal;Oncol. Lett.,2016
3. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies;Aune;Bmj,2011
4. Colorectal cancer specific conditions promote streptococcus gallolyticus gut colonization;Aymeric;Proc. Natl. Acad. Sci. U.S.A.,2018
5. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, desulfovibrio and enterococcus faecalis in the feces of patients with colorectal cancer;Balamurugan;J. Gastroenterol. Hepatol.,2008
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献